COVID vaccines have not been shown to cause cancer
Current evidence has not established that COVID vaccines cause cancer or harmful changes to people’s DNA. Some studies report cancer associations, but their methods cannot show that vaccination caused them. Traces of manufacturing DNA are real; finding a fragment is not proof of harm.
On this page
The cancer studies deserve a direct answer
A Korean study reported positive one-year cancer associations. It remains published with an October 2025 editorial concern notice. Different comparison dates, screening and healthcare use, unmeasured differences and many statistical tests complicate interpretation. Short follow-up weakens claims of newly initiated solid tumors, but does not alone rule out every acceleration hypothesis. The study does not establish causation.
Results change with the analysis
An Italian study reported a positive association with cancer hospitalization that reversed when a 12-month lag was used. Hospitalization is not the same as every new diagnosis, recurrence or cancer death. Results sensitive to such choices need further investigation; they do not prove vaccination caused cancer. The authors could not quantify important biases. A collection of case reports can raise questions but cannot estimate risk without an appropriate comparison group.
Residual DNA is a manufacturing question
Manufacturers use a DNA template to make mRNA, and small fragments can remain. An independent analysis of 15 batches found small fragments below approved limits. Eleven batches were past expiry: this sample cannot certify every vial ever made. Detecting DNA is not evidence that it changed a recipient’s genes or caused a tumor.
An SV40 sequence is not SV40 virus
A short SV40-derived regulatory sequence is different from the complete virus and does not encode its cancer-causing proteins. Harmful integration in vaccinated recipients has not been demonstrated by detecting a fragment.
An immune marker is not a cancer diagnosis
Researchers have measured antibody changes, including IgG4, and limited associations with breakthrough infection. These do not demonstrate cancer or generalized immune failure. Equally, benefits in cancer treatment or lower all-cause mortality do not logically settle every cancer-incidence question.
Current evidence has not established that COVID vaccines cause cancer or harmful changes to people’s DNA.
Keep in mind
- The findings apply to the vaccines, populations and outcomes studied. Personal recommendations depend on your health and current local guidance.
Sources you can check
Publication links open in a new tab, so you can keep your place here.
1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea (opens in a new tab)
Biomarker Research, 2025
Reports associations, not proven causation; publisher added an editorial concern notice in October 2025.
Return to reading ↑Commentary: 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea (opens in a new tab)
Frontiers in Public Health, 2026
Discusses comparison dates, healthcare use, screening, confounding and multiple comparisons.
Return to reading ↑COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province (opens in a new tab)
EXCLI Journal, 2025
Italian observational study: cancer hospitalization association reversed with a 12-month lag. Hospitalization is not every cancer diagnosis.
Return to reading ↑Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities (opens in a new tab)
npj Vaccines, 2025
15 sampled batches; 11 were past expiry. Small fragments below approved limits do not certify every vial ever made.
Return to reading ↑Response regarding residual DNA in mRNA COVID-19 vaccines (opens in a new tab)
FDA, 14 December 2023
Explains manufacturing DNA and SV40 regulatory sequences; a sequence is not an intact virus or its cancer-causing proteins.
Return to reading ↑Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination (opens in a new tab)
Science Immunology, 2023
Measures antibody changes, not generalized immune failure or cancer.
Return to reading ↑Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk (opens in a new tab)
Scientific Reports, 2026
Small cohorts; an antibody association with breakthrough infection is not proof of AIDS, cancer or a causal risk per dose.
Return to reading ↑COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France (opens in a new tab)
JAMA Network Open, 2025
Large observational comparison, median 45 months. Selection and health differences can affect all-cause mortality; does not settle pediatric risk.
Return to reading ↑COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms (opens in a new tab)
Oncotarget, 2026
Case-report-centered review also includes the Korean and Italian cohorts; it cannot estimate risk or establish causation and does not independently replicate those cohorts.
Return to reading ↑
Detailed research notes and source data
Our longer notes explain how we checked the studies, including disagreements and documents we could not get.
Download the detailed research notes →Something unclear or missing?
You can save a feedback note to share with the site owner. The form saves a file on your device; it does not send it to us.
Save a feedback note →About this draft
These pages have not completed expert review. For personal vaccine advice, talk to a clinician who knows your circumstances.
Research checked: . Wording reviewed: 2026-10-15. Version: vaccine-2026-10-15.
We revisit the page when new evidence or corrections change the answer. A public history of corrections is not available yet.